Table 2.
Biochemical features of diabetic patients with hyperglycemic crises and the healthy controls (x ± s)
| Control | DKA | NKH | |||
|---|---|---|---|---|---|
| Before treatment | After treatment | Before treatment | After treatment | ||
| Blood glucose (mmol/L) | 5.18 ± 2.76 | 23.09 ± 9.43a | 7.26 ± 4.60b | 25.86 ± 11.66a | 7.95 ± 4.38b |
| HbA1c (%) | 5.60 ± 1.28 | 13.87 ± 9.51a | 14.78 ± 6.28a | ||
| APH | 7.39 ± 2.11 | 7.19 ± 4.78a | 7.37 ± 3.15b | 7.38 ± 3.01 | 7.39 ± 4.64 |
| HCO3−(mmol/L) | 24.12 ± 2.20 | 12.35 ± 1.98a | 23.85 ± 2.67b | 23.43 ± 2.62 | 23.55 ± 3.25 |
| Ketones in urine | − | + | − | − | − |
| Effective osmolality (mmol/L) | 284.20 ± 14.71 | 280.43 ± 16.04 | 282.76 ± 14.39 | 290.62 ± 18.71 | 291.53 ± 20.35 |
| Anion gaps (mmol/L) | 12.11 ± 3.10 | 29.15 ± 5.88a | 13.56 ± 4.04b | 12.87 ± 4.80 | 11.38 ± 5.18 |
| C-peptide (nmol/L) | 0.76 ± 0.07 | 0.34 ± 0.05a | 0.35 ± 0.09a | 0.41 ± 0.09a | 0.43 ± 0.09a |
DKA: diabetic ketoacidosis group; NKH: non-ketotic hyperglycemia group; control group: healthy individuals
aP < 0.05, compared with controls
bP < 0.05, compared with the same group before treatment